Advancements in the Radioactive Tracer Technology Market
The Insight Partners
Know more about our innovative market intelligence offerings which help you achieve your critical business goals
A radioactive tracer is a chemical compound in which one or more atoms have been replaced by a radioisotope. Through monitoring its radioactive decay, a radiotracer can be used to study chemical reactions. Through different technologies, they are also used to visualize flow, including Single Photon Emission Computed Tomography (SPECT ), Positron Emission Tomography (PET), and Computed Radioactive Particle Tracking (CARPT).
Key driving factors include the factors driving radioactive tracers market growth are the rising prevalence of chronic diseases and increased use of nuclear imaging techniques are the key factors driving the growth of the market. However, the short shelf-life of radioactive tracers and availability of substitutes to nuclear diagnostic imaging procedures are hampering the market growth.?
The radioactive tracers market is majorly comprised of top players involving Rotem Industries Ltd, Abx Advanced Biochemical Compounds Gmbh, Invicro Llc; Cardinal Health Inc; Newcastle University, Novartis Ag; Curium, Blue Earth Diagnostics Limited, General Electric Co, Iba Radiopharma Solutions; among others.
The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company's growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Contact The Insight Partners for More Insights and Statistics:
Phone: +1-646-491-9876
Email: [email protected]